From New Orleans, at the annual meeting of the Society for Neuroscience
By generating antibodies that neutralize nicotine, a vaccine could keep ex-smokers from getting the nicotine high that drives many of them back to their bad habit, according to a group of neuroscientists.
“Our focus is to prevent a relapse,” says Sabina de Villiers of the Karolinska Institute in Stockholm.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.